Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population

Immunogenetics

Volumn 54, Issue 12, 2003, Pages 896-899

  Moraes, Milton O ^a   Santos, Adalberto R ^a   Schonkeren, Joris J M ^c   Vanderborght, Patrícia R ^a   Ottenhoff, Tom H M ^c   Moraes, Maria E ^b   Moraes, José R ^b   Sampaio, Elizabeth P ^a   Sarno, Euzenir N ^a   Huizinga, Tom W J ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokine; Haplotype; Interleukin 10; Polymorphism; Promoter

Indexed keywords

INTERLEUKIN 10;

ARTICLE; BRAZIL; CAUCASIAN; CYTOKINE PRODUCTION; EUROPE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; POPULATION RISK; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 0037363615     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-003-0543-3     Document Type: Article

References (22)

1. Alves-Silva J, Santos MS, Guimarães PEM, Ferreira ACS, Bandelt H-J, Pena SDJ, Prado VF (2000) The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 67:444-461
2. Carvalho-Silva DR, Santos FR, Rocha J, Pena SD (2001) The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet 68:281-286
3. Cox ED, Hoffmann SC, DiMercurio BS, Wesley RA, Harlan DM, Kirk AD, Blair PJ (2001) Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6 72:720-726
4. De Vries RR, Meera KP, Bernini LF, Loghem E van, Rood JJ van (1979) Genetic control of survival in epidemics. J Immunogenet 6:271-287
5. Eskdale J, Mc Nicholl J, Wordsworth P, Jonas P, Huizinga T, Gallagher G (1998) Interleukin-10 microsatellite polymorphism and IL-10 locus alleles in rheumatoid arthritis susceptibility Lancet 352:1282-1283
6. Eskdale J, Keijsers V, Huizinga T, Gallagher G (1999) Microsatellite alleles and single nucleotide polymorphism (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1:151-155
7. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547-550
8. Gibson AW, Edberg JC, Wu J, Westerdorp RGJ, Huizinga TWJ, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J lmmunol 166:3915-3922
9. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P (1995) Role of interleukin-10 in the lymphocyte hyperactivity and autoantibody production in human systemic lupus erythematosus. J Exp Med 1:839-844
10. Meenagh A, Williams F, Ross AO, Patterson C, Gorodezky C, Hammond M, Leheny WA, Midlleton D (2002) Frequency of cytokine polymorphisms in population from Western Europe, Africa, Asia, Middle East and South America. Human Immunol 63:1055-1061
11. Mok CC, Lanchbury JS, Chan DW, Lau CS (1998) IL-10 promoter polymorphism in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090-1097
12. Moraes ME, Fernandez-Vina M, Salatiel I, Tsai S, Moraes JR, Stastny P (1993) HLA class II DNA typing in two Brazilian population. Tissue Antigens 41:238-242
13. Moraes MO, Samo EN, Teles RMB, Saraiva BCC, Nery JAC, Sampaio EP (2000) Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients. J Invest Dermatol 115:935-941
14. Roy S, McGuire W, Mascie-Taylor CG, Saha B, Hazra SK, Hill AV, Kwiatkowski D (1997) Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 176:530-532
15. Santos AR, Almeida AS, Suffys PN, Moraes MO, Filho VF, Mattos HJ, Nery JAC, Cabello PH, Sampaio EP, Sarno EN (2000) Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in pilot study in Brazilian patients Int J Lepr 68:325-327
16. Santos AR, Suffys PN, Vanderborght PR, Moraes MO, Vieira LM, Cabello PH, Bakker AM, Matos HJ, Huizinga TW, Ottenhoff TH, Sampaio EP, Sarno EN (2002) Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis 186:1687-1691
17. Shaw MA, Donaldson IJ, Collins A, Peacock CS, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM (2001) Association and linkage of leprosy phenotypes with HLA class II and tumor necrosis factor genes. Genes Immun 2:196-204
18. Terwilliger JD, Ott J (1994) Linkage disequilibrium between alleles at marker loci 188-193. In: Handbook of human genetics linkage. The John Hopkins University Press, Baltimore
19. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8
20. Volk H, Asadullah K, Gallagher G, Sabat R, Grutz G (2001) IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets. Trends Immunol 22:414-417
21. Westerdorp RGJ, Dunne FM van, Kirkwood TBL, Helmerhost FM, Huizinga TWJ (2001) Optimizing human fertility and survival. Nat Med 7:873
22. Williams F, Meenagh A, Darke C, Acosta A, Daar AS, Gorodezky C, Hammond M, Nascimento E, Middleton D (2001) Analysis of the distribution of HLA-B alleles in the population from five continents Hum Immunol 62:645-650